News & Media Catch up with our latest releases here. Filter Article 44 Podcast 3 Video 25 Article Rob Bennett 19/12/2023 Article Rob Bennett 19/12/2023 Our year in review Our year in review Read More Article Rob Bennett 05/12/2023 Article Rob Bennett 05/12/2023 Trigeminal Neuralgia Explained Read More Article, Video Rob Bennett 20/11/2023 Article, Video Rob Bennett 20/11/2023 Oxford Cannabinoid Technologies strengthens board with CMO Dr. Tim Corn Read More Article Rob Bennett 14/11/2023 Article Rob Bennett 14/11/2023 Directorate Appointment Read More Article Rob Bennett 01/11/2023 Article Rob Bennett 01/11/2023 How our regulatory approach differs from medical cannabis Read More Article, Video Rob Bennett 31/10/2023 Article, Video Rob Bennett 31/10/2023 Oxford Cannabinoid Technologies – executive interview Read More Article Rob Bennett 24/10/2023 Article Rob Bennett 24/10/2023 Oxford Cannabinoid Technologies PLC Read More Article Rob Bennett 24/10/2023 Article Rob Bennett 24/10/2023 OCT onboards new shareholders after Phase I results Read More Article Rob Bennett 16/10/2023 Article Rob Bennett 16/10/2023 Phase I Clinical Trials Results Read More Article Rob Bennett 10/10/2023 Article Rob Bennett 10/10/2023 Phase Clinical Trial Results Read More Article, Video Rob Bennett 10/10/2023 Article, Video Rob Bennett 10/10/2023 Oxford Cannabinoid Technologies CEO says objective "absolutely met" in lead asset trial Read More Article Rob Bennett 09/10/2023 Article Rob Bennett 09/10/2023 OCT launches new website Read More Article Rob Bennett 28/09/2023 Article Rob Bennett 28/09/2023 CIPN explained Read More Article Rob Bennett 27/09/2023 Article Rob Bennett 27/09/2023 OCT Emerges Strong from a Pivotal Year, Nears Release of Milestone Clinical Trial Results Read More Article Rob Bennett 25/09/2023 Article Rob Bennett 25/09/2023 Final Dose Administered Read More Video, Article Rob Bennett 25/09/2023 Video, Article Rob Bennett 25/09/2023 Oxford Cannabinoid Technologies reports no adverse events in OCT461201 trial Read More Article Rob Bennett 19/09/2023 Article Rob Bennett 19/09/2023 A pharmaceutical approach to cannabinoids Read More Article Rob Bennett 05/09/2023 Article Rob Bennett 05/09/2023 Notice of AGM Read More Article Rob Bennett 31/08/2023 Article Rob Bennett 31/08/2023 2023 Final results Read More Article Rob Bennett 24/08/2023 Article Rob Bennett 24/08/2023 Cannabinoids vs Opioids Read More Older Posts
Article Rob Bennett 19/12/2023 Article Rob Bennett 19/12/2023 Our year in review Our year in review Read More
Article Rob Bennett 05/12/2023 Article Rob Bennett 05/12/2023 Trigeminal Neuralgia Explained Read More
Article, Video Rob Bennett 20/11/2023 Article, Video Rob Bennett 20/11/2023 Oxford Cannabinoid Technologies strengthens board with CMO Dr. Tim Corn Read More
Article Rob Bennett 01/11/2023 Article Rob Bennett 01/11/2023 How our regulatory approach differs from medical cannabis Read More
Article, Video Rob Bennett 31/10/2023 Article, Video Rob Bennett 31/10/2023 Oxford Cannabinoid Technologies – executive interview Read More
Article Rob Bennett 24/10/2023 Article Rob Bennett 24/10/2023 Oxford Cannabinoid Technologies PLC Read More
Article Rob Bennett 24/10/2023 Article Rob Bennett 24/10/2023 OCT onboards new shareholders after Phase I results Read More
Article Rob Bennett 16/10/2023 Article Rob Bennett 16/10/2023 Phase I Clinical Trials Results Read More
Article, Video Rob Bennett 10/10/2023 Article, Video Rob Bennett 10/10/2023 Oxford Cannabinoid Technologies CEO says objective "absolutely met" in lead asset trial Read More
Article Rob Bennett 27/09/2023 Article Rob Bennett 27/09/2023 OCT Emerges Strong from a Pivotal Year, Nears Release of Milestone Clinical Trial Results Read More
Video, Article Rob Bennett 25/09/2023 Video, Article Rob Bennett 25/09/2023 Oxford Cannabinoid Technologies reports no adverse events in OCT461201 trial Read More
Article Rob Bennett 19/09/2023 Article Rob Bennett 19/09/2023 A pharmaceutical approach to cannabinoids Read More